Vortex Pharma Solution ApS Financials, key figures and credit report
Gross profit 255.5 kDKK FY 2025 -58.3% vs 2024
EBIT -28.6 kDKK FY 2025 -109.1% vs 2024
Net debt - 302.4 kDKK FY 2025 +26.6% vs 2024
Quick ratio 1.4 FY 2025 -0 vs 2024
Income statement (kDKK)
2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 |
| Net sales | ||||
| Gross profit | 319.11 | -58.99 | 613.16 | 255.54 |
| Costs of management | -73.29 | - 149.42 | - 217.81 | - 127.81 |
| Costs of distribution | -18.85 | -84.68 | -80.90 | - 156.31 |
| EBIT | 226.98 | - 293.08 | 314.45 | -28.58 |
| Other financial income | 0.10 | |||
| Other financial expenses | -1.63 | -2.52 | -2.76 | -6.08 |
| Pre-tax profit | 225.35 | - 295.60 | 311.69 | -34.56 |
| Income taxes | -52.06 | -9.05 | ||
| Net earnings | 173.28 | - 295.60 | 302.63 | -34.56 |
Assets (kDKK)
2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Intangible assets total | ||||
| Tangible assets total | ||||
| Investments total | ||||
| Long term receivables total | ||||
| Inventories total | ||||
| Current trade debtors | 166.80 | 193.84 | ||
| Current other receivables | 0.01 | 4.40 | ||
| Short term receivables total | 166.80 | 193.84 | 0.01 | 4.40 |
| Cash and bank deposits | 288.41 | 85.93 | 514.55 | 405.76 |
| Cash and cash equivalents | 288.41 | 85.93 | 514.55 | 405.76 |
| Balance sheet total (assets) | 455.21 | 279.77 | 514.55 | 410.16 |
Equity and liabilities (kDKK)
2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Share capital | 40.00 | 40.00 | 40.00 | 40.00 |
| Shares repurchased | 75.00 | |||
| Other reserves | 98.28 | - 196.64 | 105.99 | 71.43 |
| Retained earnings | - 173.28 | 295.60 | - 302.63 | 34.56 |
| Profit of the financial year | 173.28 | - 295.60 | 302.63 | -34.56 |
| Shareholders equity total | 213.28 | - 156.64 | 145.99 | 111.43 |
| Non-current liabilities total | ||||
| Current trade creditors | 5.08 | 0.12 | 2.09 | 5.00 |
| Current owed to group member | 15.50 | 149.34 | 102.29 | 103.36 |
| Other non-interest bearing current liabilities | 221.33 | 286.95 | 264.18 | 190.37 |
| Current liabilities total | 241.92 | 436.41 | 368.56 | 298.73 |
| Balance sheet total (liabilities) | 455.21 | 279.77 | 514.55 | 410.16 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated